The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
Authors
Keywords
-
Journal
Trials
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-17
DOI
10.1186/s13063-020-04334-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adaptive Design: A Review of the Technical, Statistical, and Regulatory Aspects of Implementation in a Clinical Trial
- (2019) Franck Pires Cerqueira et al. Therapeutic Innovation & Regulatory Science
- A Review of Clinical Trials With an Adaptive Design and Health Economic Analysis
- (2019) Laura Flight et al. VALUE IN HEALTH
- COMPare: a prospective cohort study correcting and monitoring 58 misreported trials in real time
- (2019) Ben Goldacre et al. Trials
- Randomised trials with provision for early stopping for benefit (or harm): The impact on the estimated treatment effect
- (2019) S.D. Walter et al. STATISTICS IN MEDICINE
- Reporting of Multi-Arm Parallel-Group Randomized Trials
- (2019) Edmund Juszczak et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- TAILoR (TelmisArtan and InsuLin Resistance in HIV): An Adaptive Design Dose-Ranging Phase IIb Randomised Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-Positive Individuals on Combination Antiretroviral Therapy
- (2019) Sudeep Pushpakom et al. CLINICAL INFECTIOUS DISEASES
- CONSORT 2010 statement: extension to randomised crossover trials
- (2019) Kerry Dwan et al. BMJ-British Medical Journal
- Adaptive designs in clinical trials: why use them, and how to run and report them
- (2018) Philip Pallmann et al. BMC Medicine
- Evaluation of the extent of adaptation to sample size in clinical trials for cardiovascular and CNS diseases
- (2018) Sue-Jane Wang et al. Contemporary Clinical Trials
- Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
- (2018) Raul G. Nogueira et al. NEW ENGLAND JOURNAL OF MEDICINE
- Robustness of testing procedures for confirmatory subpopulation analyses based on a continuous biomarker
- (2018) Alexandra Christine Graf et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Are CONSORT checklists submitted by authors adequately reflecting what information is actually reported in published papers?
- (2018) David Blanco et al. Trials
- Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov
- (2018) Laura E Bothwell et al. BMJ Open
- Key design considerations for adaptive clinical trials: a primer for clinicians
- (2018) Kristian Thorlund et al. BMJ-British Medical Journal
- Key design considerations for adaptive clinical trials: a primer for clinicians
- (2018) Kristian Thorlund et al. BMJ-British Medical Journal
- Critical concepts in adaptive clinical trials
- (2018) Jay JH Park et al. Clinical Epidemiology
- Performance and predictors of recruitment success in National Heart, Lung, and Blood Institute’s cardiovascular clinical trials
- (2018) Victoria L Pemberton et al. Clinical Trials
- Design and estimation in clinical trials with subpopulation selection
- (2018) Yi-Da Chiu et al. STATISTICS IN MEDICINE
- An alternative method to analyse the biomarker-strategy design
- (2018) Cornelia Ursula Kunz et al. STATISTICS IN MEDICINE
- An adaptive population enrichment phase III trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS trial)
- (2018) C R Mehta et al. ANNALS OF ONCOLOGY
- Multi-arm multi-stage trials can improve the efficiency of finding effective treatments for stroke: a case study
- (2018) Thomas Jaki et al. BMC Cardiovascular Disorders
- Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design
- (2018) Munyaradzi Dimairo et al. BMC Medicine
- Statistical testing for baseline differences between randomised groups is not meaningful
- (2018) L. A. Harvey SPINAL CORD
- Reporting quality of randomized controlled trial abstracts in the seven highest-ranking anesthesiology journals
- (2018) Katja Janackovic et al. Trials
- Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency
- (2018) Olivier Collignon et al. Trials
- New guidance to improve sample size calculations for trials: eliciting the target difference
- (2018) Melanie L. Bell Trials
- DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial
- (2018) Jonathan A Cook et al. BMJ-British Medical Journal
- Adaptive Designs: Results of 2016 Survey on Perception and Use
- (2018) Alan Hartford et al. Therapeutic Innovation & Regulatory Science
- Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial
- (2017) Michael Stahl et al. EUROPEAN JOURNAL OF CANCER
- Guidelines for Statistical Analysis Plans
- (2017) David L. DeMets et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Guidelines for the Content of Statistical Analysis Plans in Clinical Trials
- (2017) Carrol Gamble et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trends in study design and the statistical methods employed in a leading general medicine journal
- (2017) M. Gosho et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Practical characteristics of adaptive design in phase 2 and 3 clinical trials
- (2017) A. Sato et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Bayesian clinical trial designs
- (2017) Jan O. Jansen et al. Journal of Trauma and Acute Care Surgery
- The Importance of Considering Differences in Study Design in Network Meta-analysis: An Application Using Anti-Tumor Necrosis Factor Drugs for Ulcerative Colitis
- (2017) Chris Cameron et al. MEDICAL DECISION MAKING
- Safety and efficacy of neublastin in painful lumbosacral radiculopathy
- (2017) Miroslav Backonja et al. PAIN
- Accurate p -values for adaptive designs with binary endpoints
- (2017) Stephane Heritier et al. STATISTICS IN MEDICINE
- Point estimation in adaptive enrichment designs
- (2017) Kevin Kunzmann et al. STATISTICS IN MEDICINE
- Inference for multimarker adaptive enrichment trials
- (2017) Richard Simon et al. STATISTICS IN MEDICINE
- Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility
- (2017) S. D. Walter et al. STATISTICS IN MEDICINE
- Adaptive Enrichment Designs for Stroke Clinical Trials
- (2017) Michael Rosenblum et al. STROKE
- On the Optimal Timing of Futility Interim Analyses
- (2017) Dong Xi et al. Statistics in Biopharmaceutical Research
- Estimands and Their Role in Clinical Trials
- (2017) Mouna Akacha et al. Statistics in Biopharmaceutical Research
- Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies
- (2017) Kerry N L Avery et al. BMJ Open
- Bayesian clinical trial designs
- (2017) Jan O. Jansen et al. Journal of Trauma and Acute Care Surgery
- Outcome reporting bias in randomized-controlled trials investigating antipsychotic drugs
- (2017) M Lancee et al. Translational Psychiatry
- The role of adaptive trial designs in drug development
- (2017) François Curtin et al. Expert Review of Clinical Pharmacology
- Clinical trial designs incorporating predictive biomarkers
- (2016) Lindsay A. Renfro et al. CANCER TREATMENT REVIEWS
- Bayesian survival analysis in clinical trials: What methods are used in practice?
- (2016) Caroline Brard et al. Clinical Trials
- Quantifying over-estimation in early stopped clinical trials and the “freezing effect” on subsequent research
- (2016) Hao Wang et al. Clinical Trials
- The pragmatic clinical trial in a learning health care system
- (2016) Roger J Lewis Clinical Trials
- Efficiencies of platform clinical trials: A vision of the future
- (2016) Benjamin R Saville et al. Clinical Trials
- Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol
- (2016) Gerald Heatley et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- Response-adaptive clinical trials: case studies in the medical literature
- (2016) Andrew P. Grieve PHARMACEUTICAL STATISTICS
- A multi-stage drop-the-losers design for multi-arm clinical trials
- (2016) James Wason et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Estimands in clinical trials - broadening the perspective
- (2016) Mouna Akacha et al. STATISTICS IN MEDICINE
- Attitudes and opinions regarding confirmatory adaptive clinical trials: a mixed methods analysis from the Adaptive Designs Accelerating Promising Trials into Treatments (ADAPT-IT) project
- (2016) William J. Meurer et al. Trials
- Adaptive designs undertaken in clinical research: a review of registered clinical trials
- (2016) Isabella Hatfield et al. Trials
- Addressing Challenges and Opportunities of “Less Well-Understood” Adaptive Designs
- (2016) Weili He et al. Therapeutic Innovation & Regulatory Science
- Adaptive Design Practice at the Center for Devices and Radiological Health (CDRH), January 2007 to May 2013
- (2016) Xiting Yang et al. Therapeutic Innovation & Regulatory Science
- DIA’s Adaptive Design Scientific Working Group (ADSWG)
- (2016) Eva Miller et al. Therapeutic Innovation & Regulatory Science
- Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
- (2016) Miranta Antoniou et al. PLoS One
- Are We There Yet? Early Stopping in Clinical Trials
- (2015) Robert L. Wears ANNALS OF EMERGENCY MEDICINE
- A Bayesian adaptive design for biomarker trials with linked treatments
- (2015) James M S Wason et al. BRITISH JOURNAL OF CANCER
- Sample size adjustment based on promising interim results and its application in confirmatory clinical trials
- (2015) YH Joshua Chen et al. Clinical Trials
- Simulation study for evaluating the performance of response-adaptive randomization
- (2015) Yining Du et al. Contemporary Clinical Trials
- Testing for baseline differences in randomized controlled trials: an unhealthy research behavior that is hard to eradicate
- (2015) Michiel R de Boer et al. International Journal of Behavioral Nutrition and Physical Activity
- The Platform Trial
- (2015) Scott M. Berry et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review
- (2015) Thomas Ondra et al. Journal of Biopharmaceutical Statistics
- Challenging Issues in Clinical Trial Design
- (2015) Stuart J. Pocock et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma
- (2015) Christine Léauté-Labrèze et al. NEW ENGLAND JOURNAL OF MEDICINE
- A surrogate-primary replacement algorithm for response-adaptive randomization in stroke clinical trials
- (2015) Amy S Nowacki et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Adaptive sample size modification in clinical trials: start small then ask for more?
- (2015) Christopher Jennison et al. STATISTICS IN MEDICINE
- Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls
- (2015) Peter Bauer et al. STATISTICS IN MEDICINE
- No solution yet for combining two independent studies in the presence of heterogeneity
- (2015) Andrea Gonnermann et al. STATISTICS IN MEDICINE
- Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials
- (2015) Munyaradzi Dimairo et al. Trials
- Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trials
- (2015) Munyaradzi Dimairo et al. Trials
- Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice
- (2015) Dena R Cohen et al. Trials
- Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy
- (2015) Sudeep P Pushpakom et al. BMJ Open
- Avoidable waste of research related to inadequate methods in clinical trials
- (2015) Y. Yordanov et al. BMJ-British Medical Journal
- Avoidable waste of research related to inadequate methods in clinical trials
- (2015) Y. Yordanov et al. BMJ-British Medical Journal
- CBER’s Experience With Adaptive Design Clinical Trials
- (2015) Min Lin et al. Therapeutic Innovation & Regulatory Science
- An Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic Review
- (2015) Abigail Stevely et al. PLoS One
- Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications
- (2014) Alexandra C. Graf et al. BIOMETRICAL JOURNAL
- Three steps to writing adaptive study protocols in the early phase clinical development of new medicines
- (2014) Ulrike Lorch et al. BMC Medical Research Methodology
- Evaluation of Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients
- (2014) M. D. de Jong et al. CLINICAL INFECTIOUS DISEASES
- A seamless Phase IIB/III adaptive outcome trial: Design rationale and implementation challenges
- (2014) Y H Joshua Chen et al. Clinical Trials
- Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5)
- (2014) Z. Skrivanek et al. DIABETES OBESITY & METABOLISM
- Alternative Views On Setting Clinical Trial Futility Criteria
- (2014) Paul Gallo et al. Journal of Biopharmaceutical Statistics
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Continuous Infusion of Clonidine in Ventilated Newborns and Infants
- (2014) Christoph Hünseler et al. Pediatric Critical Care Medicine
- When is a seamless study desirable? Case studies from different pharmaceutical sponsors
- (2014) Robert L. Cuffe et al. PHARMACEUTICAL STATISTICS
- Flexible sequential designs for multi-arm clinical trials
- (2014) D. Magirr et al. STATISTICS IN MEDICINE
- A comparison of Bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials
- (2014) James M. S. Wason et al. STATISTICS IN MEDICINE
- Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency
- (2014) Amelie Elsäßer et al. Trials
- Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome® for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial
- (2014) Eltahir A. G. Khalil et al. PLoS Neglected Tropical Diseases
- Adaptive Design
- (2014) Caroline Claire Morgan et al. Therapeutic Innovation & Regulatory Science
- CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
- (2013) Kenneth F. Schulz ANNALS OF INTERNAL MEDICINE
- Adaptive enrichment with subpopulation selection at interim: Methodologies, applications and design considerations
- (2013) Sue-Jane Wang et al. Contemporary Clinical Trials
- Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: A randomised clinical trial on overall survival
- (2013) W. Tröger et al. EUROPEAN JOURNAL OF CANCER
- Efficacy and Safety of Crofelemer for Noninfectious Diarrhea in HIV-Seropositive Individuals (ADVENT Trial): A Randomized, Double-Blind, Placebo-Controlled, Two-Stage Study
- (2013) Rodger D. MacArthur et al. HIV CLINICAL TRIALS
- Reporting of Noninferiority and Equivalence Randomized Trials
- (2013) Gilda Piaggio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes
- (2013) Philippe Gabriel Steg JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Optimal Timing for Interim Analyses in Clinical Trials
- (2013) Kanae Togo et al. Journal of Biopharmaceutical Statistics
- A practical guide to Bayesian group sequential designs
- (2013) Thomas Gsponer et al. PHARMACEUTICAL STATISTICS
- Exact inference for adaptive group sequential designs
- (2013) Ping Gao et al. STATISTICS IN MEDICINE
- Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
- (2013) Babak Choodari-Oskooei et al. Trials
- Similarities and Differences of Bayesian Designs and Adaptive Designs for Medical Devices: A Regulatory View
- (2013) Gregory Campbell Statistics in Biopharmaceutical Research
- Unblinded Adaptive Statistical Information Design Based on Clinical Endpoint or Biomarker
- (2013) Sue-Jane Wang* et al. Statistics in Biopharmaceutical Research
- Selective reporting of outcomes in randomised controlled trials in systematic reviews of cystic fibrosis
- (2013) Kerry Dwan et al. BMJ Open
- Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy
- (2012) Philippe Gabriel Steg et al. AMERICAN HEART JOURNAL
- A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection
- (2012) D. Magirr et al. BIOMETRIKA
- Stopping a trial early – and then what?
- (2012) Janet Wittes Clinical Trials
- Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop
- (2012) Christopher S Coffey et al. Clinical Trials
- Coordinating Data Monitoring Committees and Adaptive Clinical Trial Designs
- (2012) Jay Herson DRUG INFORMATION JOURNAL
- Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development
- (2012) Brenda Gaydos et al. DRUG INFORMATION JOURNAL
- Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease
- (2012) Ravi Thadhani et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Minimizing the Maximum Expected Sample Size in Two-Stage Phase II Clinical Trials with Continuous Outcomes
- (2012) James M. S. Wason et al. Journal of Biopharmaceutical Statistics
- On the Independence of Data Monitoring Committee in Adaptive Design Clinical Trials
- (2012) Shein-Chung Chow et al. Journal of Biopharmaceutical Statistics
- MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
- (2012) John Peter Zajicek et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Group sequential tests for delayed responses (with discussion)
- (2012) Lisa V. Hampson et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY
- Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial
- (2012) Nicholas D James et al. LANCET ONCOLOGY
- Some recommendations for multi-arm multi-stage trials
- (2012) James Wason et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Unplanned adaptations before breaking the blind
- (2012) Martin Posch et al. STATISTICS IN MEDICINE
- Biomarkers and surrogate endpoints in clinical trials
- (2012) Thomas R. Fleming et al. STATISTICS IN MEDICINE
- Optimal design of multi-arm multi-stage trials
- (2012) James M. S. Wason et al. STATISTICS IN MEDICINE
- Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial
- (2012) Matthew R Sydes et al. Trials
- Adaptive trial designs: a review of barriers and opportunities
- (2012) John A Kairalla et al. Trials
- Consort 2010 statement: extension to cluster randomised trials
- (2012) M. K. Campbell et al. BMJ-British Medical Journal
- Vitamin D Receptor Activation and Left Ventricular Hypertrophy in Advanced Kidney Disease
- (2011) Ravi Thadhani et al. AMERICAN JOURNAL OF NEPHROLOGY
- Group Sequential Methods and Software Applications
- (2011) Li Zhu et al. AMERICAN STATISTICIAN
- The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease
- (2011) Yili Pritchett et al. Clinical Trials
- A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes
- (2011) P. Barrington et al. DIABETES OBESITY & METABOLISM
- Benefits, challenges and obstacles of adaptive clinical trial designs
- (2011) Shein-Chung Chow et al. Orphanet Journal of Rare Diseases
- An adaptive confirmatory trial with interim treatment selection: Practical experiences and unbalanced randomization
- (2011) Stephane Heritier et al. STATISTICS IN MEDICINE
- Optimal multistage designs for randomised clinical trials with continuous outcomes
- (2011) James M.S. Wason et al. STATISTICS IN MEDICINE
- Adaptive Methods: When and How Should They be Used in Clinical Trials?
- (2011) Raphaël Porcher et al. THERAPIE
- The BATTLE Trial: Personalizing Therapy for Lung Cancer
- (2011) Edward S. Kim et al. Cancer Discovery
- Once-Daily Bronchodilators for Chronic Obstructive Pulmonary Disease
- (2010) James F. Donohue et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development
- (2010) Judith Quinlan et al. Clinical Trials
- A Bayesian adaptive design with biomarkers for targeted therapies
- (2010) Jens C Eickhoff et al. Clinical Trials
- Benefit–risk assessment: the use of clinical utility index
- (2010) Daniele Ouellet Expert Opinion On Drug Safety
- Stopping Randomized Trials Early for Benefit and Estimation of Treatment EffectsSystematic Review and Meta-regression Analysis
- (2010) Dirk Bassler JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Perspectives on the Use of Adaptive Designs in Clinical Trials. Part I. Statistical Considerations and Issues
- (2010) Sue-Jane Wang Journal of Biopharmaceutical Statistics
- A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis
- (2010) Jeremy Chataway et al. Multiple Sclerosis Journal
- An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints†
- (2010) Martin Jenkins et al. PHARMACEUTICAL STATISTICS
- Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design
- (2010) Peter J. Barnes et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Testing for qualitative interactions between stages in an adaptive study
- (2010) Robert A. Parker STATISTICS IN MEDICINE
- Adaptive increase in sample size when interim results are promising: A practical guide with examples
- (2010) Cyrus R. Mehta et al. STATISTICS IN MEDICINE
- Guidance for Developers of Health Research Reporting Guidelines
- (2010) David Moher et al. PLOS MEDICINE
- Adaptive Designs for Randomized Trials in Public Health
- (2009) C. Hendricks Brown et al. Annual Review of Public Health
- A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials
- (2009) Ricardo M Fernandes et al. BMC Pediatrics
- I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
- (2009) AD Barker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit
- (2009) John M Lachin Clinical Trials
- Stopping clinical trials early for benefit: impact on estimation
- (2009) Boris Freidlin et al. Clinical Trials
- Avoidable waste in the production and reporting of evidence
- (2009) Yao-long Chen et al. LANCET
- What should be the role of homogeneity testing in adaptive trials?
- (2009) Paul Gallo et al. PHARMACEUTICAL STATISTICS
- Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology
- (2009) Werner Brannath et al. STATISTICS IN MEDICINE
- Selection and bias-Two hostile brothers
- (2009) Peter Bauer et al. STATISTICS IN MEDICINE
- Adaptive designs for confirmatory clinical trials
- (2009) Frank Bretz et al. STATISTICS IN MEDICINE
- Exact Confidence Bounds Following Adaptive Group Sequential Tests
- (2008) Werner Brannath et al. BIOMETRICS
- Maintaining confidentiality of interim data to enhance trial integrity and credibility
- (2008) Thomas R Fleming et al. Clinical Trials
- Speeding up the Evaluation of New Agents in Cancer
- (2008) M. K. B. Parmar et al. JNCI-Journal of the National Cancer Institute
- CONSORT for reporting randomised trials in journal and conference abstracts
- (2008) Sally Hopewell et al. LANCET
- Adaptive design methods in clinical trials – a review
- (2008) Shein-Chung Chow et al. Orphanet Journal of Rare Diseases
- Exploring changes in treatment effects across design stages in adaptive trials
- (2008) Tim Friede et al. PHARMACEUTICAL STATISTICS
- Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias
- (2008) Kerry Dwan et al. PLoS One
- One- and two-stage design proposals for a phase II trial comparing three active treatments with control using an ordered categorical endpoint
- (2008) John Whitehead et al. STATISTICS IN MEDICINE
- Adaptive Clinical Trials
- (2008) Christopher S Coffey et al. Drugs in research & development
- CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration
- (2008) Sally Hopewell et al. PLOS MEDICINE
- Adaptive Dunnett tests for treatment selection
- (2007) Franz Koenig et al. STATISTICS IN MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now